High Flow Nasal Oxygen Therapy (Optiflow™) in High-risk Cardiac Surgical Patients

Launched by PAPWORTH HOSPITAL NHS FOUNDATION TRUST · Jul 9, 2015

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Patients are eligible for inclusion if:
• • they are aged over 18 years
• • are undergoing elective cardiac surgery (coronary artery bypass grafting, valve surgery or both)
• • they have one or more patient-related risk factor for post-operative pulmonary complications (COPD, asthma, lower respiratory tract infection in last 4 weeks, body mass index≥35 kg/m2 current (last 6 weeks) heavy smokers (\> 10 packyears)).
• • they are capable of performing a 6MWT - The 6MWT is a clinical exercise test, and is popular in clinical practice because it aids clinical decision making, and because of the belief that it provides a better estimate of functional capacity than resting cardiorespiratory measurements (24). The 6MWT is the most popular clinical exercise test, which is used for postoperative evaluation after lung surgery and has also been validated in cardiac surgery
• Exclusion Criteria:
• • Contraindication to high flow nasal oxygen such as nasal septal defect.
• • Not met extubation criteria by 10am the day after surgery (Day 1).
• • Need for CPAP pre-operatively.